About the Company : Hainan Yew Pharmaceutical Co., Ltd was established in April 2009 by its parent company, Fujian Sansan Pharmaceutical Co. Ltd, with an investment of 20 million yuan, including res...
Hainan Yew Pharmaceutical Co., Ltd was established in April 2009 by its parent company, Fujian Sansan Pharmaceutical Co. Ltd, with an investment of 20 million yuan, including research and development, production and sales. Located in Plant No.5, American Industrial Park, Haikou City ,Hainan Province , a beautiful harbour city, the workshop is built based on the new standard of GMP.
The parent company, Fujian Sansan Pharmaceutical Co. Ltd has been existed for 8 years with a total investment of 280 million yuan. It has cultivated 30 million Taxus wallichiana var. mairei Cheng et L. K. Fu covering an area of 35,800 mu, which has been put on record in State Forestry Bureau. It is the largest base of artificial cultivation of Taxus wallichiana var. mairei so far in the world.
There are two production lines in our company, Paclitaxel Active Pharmaceutical Ingredient (API) and small-volumn injection, antineoplastics included. Our company imported the most advanced facilities all over the world. The main products are Paclitaxel API, Paclitaxel Injection, Clindamycin Hydrochloride Injection, Carbonated Lidocaine Injection, Aminobutyric Injection, Adenosine Disodium Triphosphate and Magnesium Chloride Injection, Pefloxacin Mesylate Injection and Sodium Demethylcantharidate Injection. Paclitaxel is natural compound extracted from Taxus mairei, effective in cure of ovarian cancer and breast cancer.The annual output of Paclitaxel API is 144kg.
There are more than 80 staffs in our company, 77.5% of whom are professional technicians with college diploma or above. Before the establishment, our company not only repeatedly sent administrative staffs and core technicians to attend related training held by State Bureaux Training Center but also organized interior training for the junior staffs. In the days to come, we will remain the staff training system so as to make the staffs good at management, familiar with GMP, and adept at production operating skills.
The chairman of the company, Li Changming, is selected as the member of the standing committee of Taxus mairei of China Wild Plant Conservation Association. In order to meet the needs of production and further development, our company has sincerely invited professionals in pharmaceutics to join us.
